ELDN — Eledon Pharmaceuticals Share News
0.000.00%
Last trade - 00:00- $186.90m
- $137.16m
Brief: Eledon Pharmaceuticals Reports Third Quarter 2022 Operating, Financial Results
Eledon Pharmaceuticals Inc expected to post a loss of 68 cents a share - Earnings Preview
Brief: Eledon Pharmaceuticals Receives FDA Clearance Of IND Application To Evaluate Tegoprubart In IGA Nephropathy
Eledon Pharmaceuticals Inc reports results for the quarter ended in June - Earnings Summary
Brief: Eledon Pharmaceuticals Reports Second Quarter 2022 Operating And Financial Results
Eledon Pharmaceuticals Inc expected to post a loss of 70 cents a share - Earnings Preview
Brief: Eledon Pharmaceuticals Says First Patient Dosed In Phase 1B Trial Evaluating Tegoprubart In Kidney Transplantation
Brief: Eledon Pharmaceuticals Announces Orphan Drug Designation Granted To Tegoprubart
U.S. STOCKS ON THE MOVE-Outlook Therapeutics, airline and crypto stocks
U.S. STOCKS ON THE MOVE-CatchMark Timber, Yamana Gold, oil companies
Eledon up on positive data from ALS therapy study
Brief: Eledon Announces Positive Topline Results From Phase 2A Trial Of Tegoprubart Demonstrating Safety, Target Engagement, And Biomarker Response In Patients Living With Amyotrophic Lateral Sclerosis
Eledon Pharmaceuticals Inc reports results for the quarter ended in March - Earnings Summary
Brief: Eledon Pharmaceuticals Reports Q1 2022 Operating And Financial Results
Eledon Pharmaceuticals Inc expected to post a loss of 68 cents a share - Earnings Preview
NASDAQ RESUMED AT 10:10 AM
NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 10:05 AM
Eledon Pharmaceuticals Inc reports results for the quarter ended in December - Earnings Summary
Eledon Pharmaceuticals Inc expected to post a loss of 75cents a share - Earnings Preview